ANXIOLYTICS, SEDATIVES AND HYPNOTICS Flashcards
Describe CENTRAL GABA-MEDIATED INHIBITION
- short axon GABA interneurones in the brain –> has regulatory role
- keep firing rates within certain parameters
Glutamate = precursor for GAB
GLU –> converted to GABA (via GAD)
- GABA = stored in vesicle in presynaptic terminal
-
-
Describe the synthesis of GABA
Glutamate = precursor for GAB GLU --> converted to GABA (via GAD) - GABA = stored in vesicle in presynaptic terminal - until depolarization occurs - VGCC opens - Causes exocytosis
- chloride flows into post synaptic cell –> causes hyperpolarisation
Describe the metabolism of GABA
- GABA = converted to –> Succinic semialdehyde (SSDH)
- via GABA- Transaminase - SSDH = converted to –> Succinic Acid
- via succinic semialdehyde dehydrogenase
Succinic Acid - goes back o TCA Cycle
NOTE:
GABA-T + SSDH = Mitochondrial enzymes
- Inhibitors of GABA Metabolism leads to large accumulation of Brain GABA
Anticonvulsive drugs:
- SODIUM VALPROATE (EPILIM)
- -> SSDH + GABA T inhibitor
- VIGABATRIN (SABRIL)
Describe the reuptake of GABA
- primary inactivation method of GABA
- uptake into glial cells / presynaptic cells
- GABA –> converted to SSA (Via GABA-T)
describe the structure of the GABAa receptor complex
- GABA receptor protein
- Barbiturate receptor protein
- BDZ receptor protein
- chloride channel protein
GABAA receptor complex: (post-synaptic) 4 main proteins (not inc. modulin)
- GABA binds GABA receptor protein à links w/ BDZ receptor protein mediated by GABA modulin à opens Cl- channel proteins
- If BDZ binds BDZ receptor protein à enhances GABA action on Cl- channel
o Also, binding/affinity of GABA is enhanced
o This is reciprocal: binding of GABA enhances affinity of BDZ too
- BARB enhances GABA action at Cl- channel + GABA affinity (not reciprocal)
o At high doses, BARBs directly stimulate Cl- channel
- Triangle = Bicuculline is competitive GABAA receptor antagonist
- Rectangle = Flumazenil is competitive BDZ antagonist
how do Bz + Barbs similar / differ
SIMILARITY:
- No activity alone b/c work by enhancing GABA (allosteric action
DIFFERENCE:
- -> Different binding sites + mechanisms:
- BZs increase frequency of openings (same duration)
- BARBs increase duration of openings (no frequency change)
–> BARBs = less selective than BZs
o Cause decreased excitatory transmission
o Other membrane effects e.g. at high doses
o May explain why:
- BARBs can induce surgical anaesthesia (BZs can’t do this)
- BARBS have low margin of safety
What are some clinical uses of BZs + BARBS ?
ANAESTHETICS (BARBs ONLY : THIOPENTONE)
ANTICONVULSANTS (DIAZEPAM; CLONAZEPAM; PHENOBARBITAL)
ANTI-SPASTICS (DIAZEPAM)
ANXIOLYTICS
SEDATIVES / HYPNOTICS
define anxiolytics
anxiolytics : REMOVE ANXIETY WITHOUT IMPAIRING MENTAL OR PHYSICAL ACTIVITY
Define sedatives
SEDATIVES: REDUCE MENTAL AND PHYSICAL ACITVITY WITHOUT PRODUCING LOSS OF CONSCIOUSNESS
Define Hypnotics
HYPNOTICS: INDUCE SLEEP
BZ + BARBS clinically
IDEALLY: THEY SHOULD:
i) HAVE wide / narrow MARGIN OF SAFETY
ii) depress / not depress RESPIRATION
iii) produce/ do not produce NATURAL SLEEP (HYPNOTICS)
iv) interacts / doest interact WITH OTHER DRUGS
v) produces / doesn’t produce ‘HANGOVERS’
vi) produces / doesn’t produce DEPENDENCE
- IDEALLY: THEY SHOULD:
i) HAVE WIDE MARGIN OF SAFETY
ii) NOT DEPRESS RESPIRATION
iii) PRODUCE NATURAL SLEEP (HYPNOTICS)
iv) NOT INTERACT WITH OTHER DRUGS
v) NOT PRODUCE ‘HANGOVERS’
vi) NOT PRODUCE DEPENDENCE
What are clinical uses of barbiturates?
what is half life of barbiturates
- sedative / hypnotic
- -> Amobarbital
- -> severe intractable insomnia
- -> Half life = 20 - 25hrs
What are unwanted effects of barbiturates?
- DEPRESS RESPIRATION
- OVERDOSING = LETHAL
- alters natural sleep (decreases REM) –> Hangovers / Irritability
- potentiates effects of other CNS Depressants e.g alcohol
- enzyme inducers
- tolerance development
- withdrawal syndrome (insomnia, anxiety, tremor, convulsions, death)
Describe the pharmacokinetics of Benzodiazepines
- PEAK [PLASMA] ~ 1h
- binds to plasma proteins strongly
- highly lipid soluble
- metabolized extensively in liver
- excreted via urine (glucuronide conjugates)